Irizarry-Alvarado Joan M, Dwyer Jamie P, Brumble Lisa M, Alvarez Salvador, Mendez Julio C
Division of General Internal Medicine, Mayo Clinic, Jacksonville, Florida, USA.
AIDS Read. 2009 Mar;19(3):114-21.
We report 3 cases of patients with HIV/AIDS in whom Fanconi syndrome and nephrogenic diabetes insipidus developed secondary to use of an antiretroviral regimen containing tenofovir disoproxil fumarate and didanosine. These patients presented with a history of polydipsia, polyuria, weight loss, anorexia, and wasting. Interestingly, 1 patient was not taking protease inhibitors. This response is a well-documented yet uncommon complication of tenofovir use in the HIV population. We recommend continued monitoring for renal toxicity when using NRTI combination of tenofovir and didanosine.
我们报告了3例感染人类免疫缺陷病毒/获得性免疫缺陷综合征(HIV/AIDS)的患者,他们因使用含富马酸替诺福韦二吡呋酯和去羟肌苷的抗逆转录病毒治疗方案而继发范科尼综合征和肾性尿崩症。这些患者有烦渴、多尿、体重减轻、厌食和消瘦的病史。有趣的是,1例患者未服用蛋白酶抑制剂。这种反应是替诺福韦在HIV人群中使用时一种有充分文献记载但并不常见的并发症。我们建议在使用替诺福韦和去羟肌苷的核苷类逆转录酶抑制剂联合用药时持续监测肾毒性。